Ultivue Inc.
Cambridge, MA Part of Vizgen Inc.
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
KRW4BMDMFP39
-
Parent
KRW4BMDMFP39
- SAM.gov registration date
- Physical address
- 763 Concord Ave, Cambridge, MA 02138, USA
- Website
- vizgen.com
- Founded
- 2019
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $53,940 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Software | National Cancer Institute (NIH) | $15,000 | |
| Software | National Cancer Institute (NIH) | $14,000 | |
| Biological kits | National Cancer Institute (NIH) | $24,940 | |
| Proximity DNA exchange imaging | National Cancer Institute (NIH) | $299,717 |
Similar vendors
About the company
Ultivue Inc. is a for-profit corporate entity registered in the System for Award Management (SAM.gov) since September 2015, with a registration valid through April 2025. Based on the available contract award information, the company appears to specialize in providing scientific and technological solutions primarily to federal research agencies, with a particular focus on biological and software-related products. While specific details about the company's full background are not provided, the contract awards suggest Ultivue Inc. operates in the life sciences and biotechnology sector, likely providing specialized research tools and software solutions to scientific institutions.
The company has secured multiple federal contract awards from the National Cancer Institute, a civilian agency under the Department of Health and Human Services (HHS) National Institutes of Health (NIH). These contracts, ranging from $14,000 to $24,940, have been predominantly purchase order-style agreements for specific scientific products. The contract awards demonstrate Ultivue Inc.'s capability to provide biological kits and software solutions, with recent awards focused on delivering specialized research materials. None of the contract awards utilized set-aside designations, indicating the company competes in open federal procurement processes. The contracts have consistent performance periods through mid-to-late 2024 and early 2025, with a geographic connection to Cambridge, Massachusetts, suggesting the company is likely based in or near this scientific and technological hub. The contract awards reveal a consistent pattern of supplying scientific research materials and software to federal research institutions, particularly within the cancer research domain.
Quick answers
Is Ultivue Inc. registered in SAM.gov?
Yes. Ultivue Inc.'s SAM.gov registration is active through June 10, 2027.
What is Ultivue Inc.'s CAGE code?
Ultivue Inc.'s CAGE code is 7FZ11, and its Unique Entity ID (UEI) is ZE23LFTC5SV3.
How much has Ultivue Inc. received in federal contracts?
Federal contracts obligated $53,940 to Ultivue Inc. in fiscal years 2023 through 2027.
What is Ultivue Inc.'s most recent federal award?
Ultivue Inc.'s most recent federal contract award is Software (75N91024P00730), from National Cancer Institute (NIH), on September 15, 2024.
On GovTribe
See Ultivue Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors